|
ESYT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.548400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.461170E-01 |
| Normal-vs-Stage2 |
4.761200E-01 |
| Normal-vs-Stage3 |
9.814400E-01 |
| Normal-vs-Stage4 |
8.508000E-01 |
| Stage1-vs-Stage2 |
8.914200E-01 |
| Stage1-vs-Stage3 |
2.902800E-01 |
| Stage1-vs-Stage4 |
4.795800E-01 |
| Stage2-vs-Stage3 |
5.305800E-01 |
| Stage2-vs-Stage4 |
5.294400E-01 |
| Stage3-vs-Stage4 |
8.486800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.094550E-01 |
| Normal-vs-AfricanAmerican |
4.851600E-01 |
| Normal-vs-Asian |
2.701600E-01 |
| Caucasian-vs-AfricanAmerican |
4.741400E-01 |
| Caucasian-vs-Asian |
2.868600E-01 |
| AfricanAmerican-vs-Asian |
2.884000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.931430E-01 |
| Normal-vs-Female |
4.973600E-02 |
| Male-vs-Female |
2.405800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.087600E-01 |
| Normal-vs-Extreme_Weight |
3.797200E-01 |
| Normal-vs-Obese |
7.081600E-02 |
| Normal-vs-Extreme_Obese |
7.297800E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.166800E-01 |
| Normal_Weight-vs-Obese |
4.120400E-02 |
| Normal_Weight-vs-Extreme_Obese |
9.011800E-01 |
| Extreme_Weight-vs-Obese |
4.517400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.942800E-01 |
| Obese-vs-Extreme_Obese |
2.045200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.735700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.267680E-02 |
| Normal-vs-Age(61-80Yrs) |
8.067600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.485200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.157600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.397000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.763800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.331930E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.103800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.718400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.844400E-03 |
| Normal-VS-Type2 PRCC |
1.024980E-01 |
| Normal-VS-KIRP CIMP |
1.015690E-02 |
| Normal-VS-Unclassified PRCC |
3.554200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.79209999999453E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.352800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.053000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.401100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.155100E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.259600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.913180E-01 |
| Normal-vs-N1 |
9.075000E-01 |
| Normal-vs-N2 |
6.971800E-01 |
| N0-vs-N1 |
2.487000E-01 |
| N0-vs-N2 |
4.117600E-01 |
| N1-vs-N2 |
8.322800E-01 |
|
|
